Dr. Sumati Virendra Gupta, MD

Dr. Gupta practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Gupta's NPI, 1003906603, was assigned on October 13, 2006. Dr. Gupta graduated from Seth G.S. Medical College in 1997. Dr. Gupta holds Utah license 5085712-1205.

Dr. Gupta's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Gupta's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Gupta is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Gupta to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gupta practices, 3 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Dr. Gupta's primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dr. Gupta is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gupta's licenses on file in 4 states: Utah, Texas, Georgia and North Carolina.

Dmand AI lists tobacco use among the conditions Dr. Gupta treats.

CMS data shows 483 Medicare services from Dr. Gupta across 5 procedure codes in 2024, for 78 Medicare patients. Medicare paid $25,905 for them.

CMS counts 78 Medicare patients who saw Dr. Gupta in 2024. The largest group is 75 to 84, with 35 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gupta's median patient age at 73, with 26% women.

In 2024, Dr. Gupta wrote 488 Medicare Part D claims for 69 patients. 71% of them were for generic drugs. CMS names the drug for 322 of them, across 15 drugs with 11 or more claims each, at $1,161,757 in total drug cost. In 2023, CMS named 281 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Gupta for performance year 2024, reported as part of a group. Dr. Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gupta as offering telehealth.

Dmand AI links 71 papers to Dr. Gupta, published from 2010 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Carcinoma, Transitional Cell, Urinary Bladder Neoplasms and Antineoplastic Combined Chemotherapy Protocols. Dr. Gupta has published most often in J Immunother Cancer. Dr. Gupta's most frequent co-authors are Benjamin Louis Maughan, MD, Petros Grivas, MD and Neeraj Agarwal, MD.

Dmand AI links Dr. Gupta to 10 clinical trials, 5 of them phase 1 studies. 5 are still active or recruiting. Conditions studied include Urinary Bladder Neoplasms, Carcinoma, Transitional Cell and Urinary Bladder Diseases. University of Utah sponsors the most, 3.

CMS Open Payments shows 18 general payments to Dr. Gupta from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Incyte Corporation paid the most, $2,133. It also lists 8 research payments totaling $4,038 from 2022 to 2023.

Dr. Gupta graduated from Seth G.S. Medical College in 1997.

Dr. Gupta is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.